On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneﾒs single-dose intranasal vaccine…
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
On Apr. 2, 2020, the FDAﾗin collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On May 20, 2010, researchers at the J. Craig Venter Institute in Maryland published results describing the successful…
In 2010, Hanger announced that it was relocating its corporate headquarters from Bethesda, MD to Austin, TX. In…
In 2008, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCC) received NCI designation, a…
On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
In 2000, the Georgetown University Hospital became part of MedStar Health, a not-for-profit network of seven hospitals in…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Nov. 4, 1997, Vice President Al Gore and Senator Mark O. Hatfield attended groundbreaking ceremonies for the…
In 1996, the University of Maryland Cancer Center was renamed Marlene and Stewart Greenebaum Comprehensive Cancer Center. In…